Finance

Lists
BNXT:CNSX
BioNxt Solutions Inc
CA$0.35
0.00%
(0.00) 1D
Sep 30, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BNXT...
Open
CA$0.35
High
CA$0.35
Low
CA$0.35
Mkt. cap
47.63M
Avg. vol.
37.65K
Volume
5.00K
52-wk high
CA$0.91
52-wk low
CA$0.28
EPS
-CA$0.07
No. of employees
20
Open
CA$0.35
High
CA$0.35
Low
CA$0.35
Mkt. cap
47.63M
Avg. vol.
37.65K
Volume
5.00K
52-wk high
CA$0.91
52-wk low
CA$0.28
EPS
-CA$0.07
No. of employees
20
News stories
From web sources and news partners
About BioNxt Solutions Inc
CEO-
Employees20
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitebionxt.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.26K
-11.26K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
137.70K
190.50K
89.15K
285.97K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
997.10K
1.05M
668.41K
340.49K
Operating expense
1.28M
1.73M
2.78M
899.82K
Total operating expenses
1.28M
1.73M
2.78M
899.82K
Operating income
-1.27M
-1.75M
-2.78M
-899.82K
Other non operating income
-27.60K
-24.60K
-11.40K
-46.65K
EBT including unusual items
-1.60M
-2.34M
-4.25M
-1.15M
EBT excluding unusual items
-1.56M
-2.32M
-3.18M
-1.26M
Income tax expense
-
-197.47K
-
-
Effective tax rate
-
8.42%
-
-
Other operating expenses
-
-
-
-
Net income
-1.60M
-2.15M
-4.25M
-1.15M
Net profit margin
-14,248.03%
19,073.55%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-380.64K
-422.10K
-369.04K
-381.91K
Net interest expenses
-380.64K
-422.10K
-369.04K
-381.91K
Depreciation and amortization charges
5.55K
4.49K
1.06K
725.00
EBITDA
-1.26M
-1.74M
-2.78M
-899.09K
Gain or loss from assets sale
-15.11K
69.62K
-61.94K
-19.36K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps